Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farrelly

Showing results (691-700 of 747) with videos related to

Pageof 75
Sort By:
ESMO Open|February 20, 2021
Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trialJ A Ledermann, A C Embleton-Thirsk, T J Perren, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2025
Systemic in utero gene editing as a treatment for cystic fibrosisAdele S Ricciardi, Christina Barone, Rachael Putman, et al.
Thorax|June 2, 2025
Performance of volume and diameter thresholds in malignancy prediction of solid nodules in lung cancer screeningAndrew W Creamer, Carolyn Horst, Ruth Prendecki, et al.
Preventive Medicine|February 2, 2020
Current recommendations on the selection of measures for well-beingTyler J VanderWeele, Claudia Trudel-Fitzgerald, Paul Allin, et al.
Journal of Translational Medicine|May 2, 2021
Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancerM Janusz Mezynski, Angela M Farrelly, Mattia Cremona, et al.
Surgery in Practice and Science|July 28, 2023
Current use of the National Surgical Quality Improvement Program surgical risk calculator in academic surgery: a mixed-methods studySamuel M Miller, Sara Abou Azar, James S Farrelly, et al.
Thorax|July 21, 2022
Telephone risk-based eligibility assessment for low-dose CT lung cancer screeningJennifer L Dickson, Helen Hall, Carolyn Horst, et al.
Lancet (London, England)|March 31, 2016
Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trialJonathan A Ledermann, Andrew C Embleton, Fharat Raja, et al.
Nature Communications|June 13, 2024
Histone serotonylation in dorsal raphe nucleus contributes to stress- and antidepressant-mediated gene expression and behaviorAmni Al-Kachak, Giuseppina Di Salvo, Sasha L Fulton, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
Histone H3 serotonylation dynamics in dorsal raphe nucleus contribute to stress- and antidepressant-mediated gene expression and behaviorAmni Al-Kachak, Sasha L Fulton, Giuseppina Di Salvo, et al.
Pageof 75

Showing results (691-700 of 747) with videos related to

Sort By:
Pageof 75
ESMO Open|February 20, 2021
Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trialJ A Ledermann, A C Embleton-Thirsk, T J Perren, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2025
Systemic in utero gene editing as a treatment for cystic fibrosisAdele S Ricciardi, Christina Barone, Rachael Putman, et al.
Thorax|June 2, 2025
Performance of volume and diameter thresholds in malignancy prediction of solid nodules in lung cancer screeningAndrew W Creamer, Carolyn Horst, Ruth Prendecki, et al.
Preventive Medicine|February 2, 2020
Current recommendations on the selection of measures for well-beingTyler J VanderWeele, Claudia Trudel-Fitzgerald, Paul Allin, et al.
Journal of Translational Medicine|May 2, 2021
Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancerM Janusz Mezynski, Angela M Farrelly, Mattia Cremona, et al.
Surgery in Practice and Science|July 28, 2023
Current use of the National Surgical Quality Improvement Program surgical risk calculator in academic surgery: a mixed-methods studySamuel M Miller, Sara Abou Azar, James S Farrelly, et al.
Thorax|July 21, 2022
Telephone risk-based eligibility assessment for low-dose CT lung cancer screeningJennifer L Dickson, Helen Hall, Carolyn Horst, et al.
Lancet (London, England)|March 31, 2016
Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trialJonathan A Ledermann, Andrew C Embleton, Fharat Raja, et al.
Nature Communications|June 13, 2024
Histone serotonylation in dorsal raphe nucleus contributes to stress- and antidepressant-mediated gene expression and behaviorAmni Al-Kachak, Giuseppina Di Salvo, Sasha L Fulton, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
Histone H3 serotonylation dynamics in dorsal raphe nucleus contribute to stress- and antidepressant-mediated gene expression and behaviorAmni Al-Kachak, Sasha L Fulton, Giuseppina Di Salvo, et al.
Pageof 75